BioCentury | Apr 15, 2013
Company News

Novopharm Biotech board of directors update

...Biotech (TSE:NVO), Toronto, Ontario Business: Cancer, Infectious diseases/AIDS Appointed: Michael Tarnow, president and CEO of Creative BioMolecules Inc....
BioCentury | Apr 15, 2013
Company News

Novopharm Biotech Inc. board of directors update

...Inc. (TSE:NVO), Toronto, Ontario Business: Cancer, Infectious diseases/AIDS Appointed: Michael Tarnow, president and CEO of Creative BioMolecules Inc....
BioCentury | Oct 10, 2011
Product Development

Bone-free BMP

...BMP has been in development for kidney disease at least since the mid-'90s. In 1996, Creative BioMolecules Inc....
BioCentury | Jan 30, 2006
Product Development

Hedging on formulation

...the target itself. Since its formation in 2000 by way of a three-way merger between Creative BioMolecules Inc....
BioCentury | Jul 7, 2003
Finance

Helping push open a window

...biotech bear markets and the eventual opening of the window for new paper.95-96 windowA12/21/94 - Creative BioMolecules...
BioCentury | Feb 10, 2003
Company News

EntreMed board of directors update

...ENMD), Rockville, Md. Business: Cancer Appointed: Michael Tarnow as chairman, former president and CEO of Creative BioMolecules Inc. WIR...
BioCentury | Jan 8, 2001
Clinical News

Recombinant osteogenic protein 1 regulatory update

...in cases where previous autograft treatment has failed or is unfeasible. OP-1 was developed by Creative BioMolecules Inc....
BioCentury | Jan 2, 2001
Company News

Gliatech management update

...Hired: Steven Basta as president, formerly CFO and VP of finance and business development at Creative BioMolecules Inc....
BioCentury | Dec 18, 2000
Company News

Basta appointed president of GLIA

...Prior to joining GLIA, Basta was CFO and VP of finance and business development for Creative BioMolecules...
BioCentury | Sep 18, 2000
Company News

Anadys management update

...SVP of Boston operations and general counsel, formerly general counsel and VP of administration at Creative BioMolecules Inc. WIR...
Items per page:
1 - 10 of 97
BioCentury | Apr 15, 2013
Company News

Novopharm Biotech board of directors update

...Biotech (TSE:NVO), Toronto, Ontario Business: Cancer, Infectious diseases/AIDS Appointed: Michael Tarnow, president and CEO of Creative BioMolecules Inc....
BioCentury | Apr 15, 2013
Company News

Novopharm Biotech Inc. board of directors update

...Inc. (TSE:NVO), Toronto, Ontario Business: Cancer, Infectious diseases/AIDS Appointed: Michael Tarnow, president and CEO of Creative BioMolecules Inc....
BioCentury | Oct 10, 2011
Product Development

Bone-free BMP

...BMP has been in development for kidney disease at least since the mid-'90s. In 1996, Creative BioMolecules Inc....
BioCentury | Jan 30, 2006
Product Development

Hedging on formulation

...the target itself. Since its formation in 2000 by way of a three-way merger between Creative BioMolecules Inc....
BioCentury | Jul 7, 2003
Finance

Helping push open a window

...biotech bear markets and the eventual opening of the window for new paper.95-96 windowA12/21/94 - Creative BioMolecules...
BioCentury | Feb 10, 2003
Company News

EntreMed board of directors update

...ENMD), Rockville, Md. Business: Cancer Appointed: Michael Tarnow as chairman, former president and CEO of Creative BioMolecules Inc. WIR...
BioCentury | Jan 8, 2001
Clinical News

Recombinant osteogenic protein 1 regulatory update

...in cases where previous autograft treatment has failed or is unfeasible. OP-1 was developed by Creative BioMolecules Inc....
BioCentury | Jan 2, 2001
Company News

Gliatech management update

...Hired: Steven Basta as president, formerly CFO and VP of finance and business development at Creative BioMolecules Inc....
BioCentury | Dec 18, 2000
Company News

Basta appointed president of GLIA

...Prior to joining GLIA, Basta was CFO and VP of finance and business development for Creative BioMolecules...
BioCentury | Sep 18, 2000
Company News

Anadys management update

...SVP of Boston operations and general counsel, formerly general counsel and VP of administration at Creative BioMolecules Inc. WIR...
Items per page:
1 - 10 of 97